The retinal vascular complications in patients receiving cephalic radiation for vari ous lesions over a ten year period were reviewed. The incidence of retinopathy was 17% overall, but increased with proximity of the treatment site to the eye, being highest in irradiation of the eye/orbit (85.7%), paranasal sinuses (45.4%) and naso pharynx (36.4%). The risk of retinopathy increased significantly when the total dose of radiation exceeded 3000 cGy.
The eye and ocular adnexae are vulnerable to ionising radiation although the susceptibility of the individual tissues shows great variation. I Radiation damage to ocular tissues is' also related to the cumulative dose of radiation,2--4 the dose fractionation5,6 and the energy of the radiation beam.3, 7 The eye may sustain direct radiation damage during radiotherapy for ocular and adnexal tumours or receive indirect injury from gratuitous radiation during the treatment of more remote tumours of the head and neck. The extent of ocular damage from gratuitous radiation can be lim ited by prophylactic shielding, the use of multiple therapeutic portals and the employ ment of coherent radiation sources with low scatter characteristics. Nevertheless despite improvements in radiotherapeutic methods and shielding techniques, it is often difficult for the radiotherapist to treat adequately many deep-seated cephalic tumours without irradiating the posterior orbit and eye. 4 There have been several reports of ocular complications following radiotherapy to tum ours of the nasopharynx,8.1 0 the paranasal sin uses9 , 1J,12 and the central nervous system. 13.15 Other workers have recorded ocular pathol ogy secondary to orbital and ocular radiation particularly in cases of orbital lymphoma, 1 6, 17 retinoblastoma 1 6 , 18 and choroidal melan oma.1 6 No study, as yet, has determined the relative risks of developing radiational ret inopathy with regard to the site of primary treatment and to determine this we conducted a retrospective study of all patients in Northern Ireland receiving cephalic radiation over a period of ten years.
Materials and Methods
An initial pool of subjects was drawn from patients attending the Northern Ireland *This investigation as supported by a grant from the British Council for Prevention of Blindness.
Correspondence to: Department of Ophthalmology, The Queen's University of Belfast, Eye and Ear Clinic, Royal Victoria Hospital , Belfast BT12 6BA. All surviving patients in this group were invited to attend the Eye and Ear Clinic, Royal Victoria Hospital where they had ocular biomicroscopy, fundoscopy, ocular electrophysiology and measurement of visual function. Fundus photography and fluores cein angiography were carried out where ret inopathy was suspected or present. Fifteen patients who had significant ocular radiation but no retinal vasculopathy had fluorescein angiography to determine whether subtle changes had occurred at the level of the ret inal pigment epithelium. Patients with radi ation vasculopathy had a full systemic examination and laboratory investigations to exclude diabetes, hypertension, collagen disease or other associated vasculopathy. Patients, who were too ill to attend or had emigrated were excluded from the study.
Results
Ninety four patients, out of a possible total of 140, (70%) attended the Eye clinic for assess ment. The age range was 41 years to 86 years (mean 49.5). There were 52 males and 42 females.
Incidence
Sixteen patients were found to have radiation vasculopathy and retinal pigment epithelial changes (17% ), eleven males and five females. The incidence of radiation retino pathy with respect to the site of primary path ology (Table I) was highest for orbital and eye radiation. Radiation of the nasal cavities, paranasal sinuses and nasopharynx also had a high incidence of post treatment retinopathy. The only patient receiving intracranial radiation to develop retinopathy was also dia betic and had received concurrent chemo therapy 1-(2-chlorethyl)-3-cyclohexyl-. 1-nitrosurea (CCNU). Radiotherapy to cephalic tumours more remote from the eye, eg ear, mouth and salivary glands carried no. risk of retinopathy within the follow-up time of this study.
Distribution
Radiation retinopathy was unilateral in ten patients and bilateral in six patients (Table  II) . Patients developing retinopathy sub sequent to treatment of nasopharyngeal tum ours, had involvement of both eyes and in three of four patients in this group the ret· inopathy was similar both in terms of severity and distribution. Patients receiving treatment for lesions of the eye, orbit or maxillary antrum had only involvement of the ipsilat eral eye.
Morphological Features
The radiation vasculopathy consisted mostly of micro aneurysms and fusiform and saccular dilatations of the retinal microvasculature (Table III) . These alterations were largely concentrated in the macular and peripapillary regions (Fig. 1) . Two patients, however, who had eccentric radiation of the eyes (Patients 11 and 16) developed asymmetrical retino pathy which corresponded with the field of radiation.
Other retinopathic changes included intra retinal haemorrhages, hard and soft exudates and.intraretinal microvascular abnormalities. Striking caJibre changes were also noted in arterioles and veins particularly beading and sheathing (Fig. 1) . One patient has extensive inner retinal ischaemia, preretinal neovascu larisation and preretinal haemorrhage. Three patients had optic atrophy attributable to radiation, however, a number of patients with intracranial neoplasms had optic atrophy that was considered primary to the disease process.
Of the 94 study patients, five had evidence of systemic vascular disease, three with diabetes and two were receiving treatment for hypertension at the time of radiotherapy. Two of the three diabetic patients developed evi dence of radiation retinopathy. One diabetic, noted above, had bilateral asymmetrical ret inopathy corresponding with the field of radi ation eccentric to the eye. A second patient diagnosed diabetic one year prior to the commencement of radiotherapy for a naso pharyngeal tumour developed bilateral ret inopathic changes three years after treatment. A third diabetic patient receiving radio therapy for nasopharyngeal cancer did not develop any retinopathy. This patient, how ever, only survived two years following treat ment for the tumour. A further patient was diagnosed diabetic six years following radio therapy for a right orbital lymphoma. This individual was found to have radiation vas culopathy in the eye receiving radiotherapy one year prior to the diagnosis of diabetes. None of the patients with systemic hyper tension developed retinopathy following radiotherapy.
Three patients whose fundi could not be inspected because of medial opacities were presumed to have radiational retinopathy. All three patients had advanced rubeosis iridis and neovascular glaucoma and had received high doses of radiation to the unprotected eye (Table III) .
Fluorescein Angiography
In radiation retinopathy fluorescein angio graphy demonstrated striking and character- istic changes in the architecture of the retinal microvasculature with varying degrees of cap illary incompetence and closure. In early disease the affected capillary bed was grossly dilated and interspersed with numerous microaneurysms (Fig. 2) . Deformed capillar ies stained vividly with dye in the later phase of angiography but often remained relatively competent.
As the retinopathy developed the micro vasculature became incompetent with evi dence of focal and generalised macular oedema (Fig. la,b) In more advanced disease capillary dropout was a feature (Figs. la,b) and in some patients focal or generalised areas of inner retinal ischaemia were identified (Fig. 3) .
Chemotherapy
Eleven of the 94 study patients received adjunctive chemotherapy with various agents (tamoxifen, vincristine, actinomycin, 5-flu orouracil and 1-(2-chlorethyl)-3-cyclo hexly-l-nitrosurea). Seven of the above 11 patients who had received chemotherapy developed radiation vasculopathy (Table I) .
Anterior Segment Changes
Anterior segment complications of radiation included neovascular glaucoma (NVG), cat aract, corneal vascularisation, corneal oedema, superficial punctate keratitis (SPK), keratoconjunctivitis, conjunctival leukopla kia, madarosis, trichiasis and eyelid telangiec- tasia. Anterior segment complications occurred predominantly in patients treated for eYI:! and orbital tumours and in those receiving therapy for tumours of the nose and paranasal sinuses. Anterior segment compli cations were absent in patients receiving treatment for nasopharyngeal and intra cranial tumours.
Visual Acuity
Visual acuity was assessed in 22 eyes (16 patients) with identifiable retinopathy (Tables  III and IV) . Thirteen eyes with mild retino pathy, ie micro aneurysms and dilated capil laries had a corrected visual acuity of 6/9 or better. Three of these eyes had extracapsular cataract extraction (ECCE) and intraocular lens implantation (IOL). The time from radiotherapy to final measurement of visual acuity was 2. 5 to eleven years (mean seven years). Two eyes with moderate retinopathy, ie micro aneurysms , dilated capillaries and ret inal ischaemia, and evidence of macular oedema in one eye (Patient 12), had corrected visual acuities of 6/18 and 6/12. In one patient (Patient 11) cataract formation was judged to have contributed significantly to the visual decline. The time from radiotherapy to assessment of visual acuity in these patients was five and six years.
Four eyes with severe retinopathy, ie advanced and widespread microvascular changes, inner retinal ischaemia and maculo pathy had a corrected visual acuity between 6/18 and 6/60, with a follow-up period of eight to'ten years. Two patients in this group had laser photocoagulation for macular oedema.
Three eyes with bare perception or no perception of light were presumed to have advanced ischaemic retinopathy on the basis of having advanced rubeosis iridis and neo vascular glaucoma. All these eyes also had entrenched keratopathy and advanced cataract.
Natural Course
Because of the retrospective nature of the study it was not possible to calculate the latency of micro angiopathy with any degree of accuracy. The interval between radiation treatment and the detection of radiational retinopathy in this series varied between one and 8. 5 years (mean 4.7 years). Eight of the 16 patients were followed up for a period of two to four years. One patient with miCI'oaneu-6/9 or better 2.5-11 (7) 6/12--6/18 5--6 (5.5) 6/18--6 /60 (2 eyes-laser PIC) 8-11 (10) PL-NPL 3.5-5 (4) rysms showed no significant change over a period of three years. A further patient with moderately advanced radiation retinopathy showed some slight improvement over a period of five years. The remaining six patients all showed microangiopathic deterio ration with capillary dropout, increase in the number of microvascular abnormalities and intensification of macular oedema.
Treatment
Two patients (Patients 1 and 7) in the present series received laser photocoagulation for radiation retinopathy. Both patients devel oped exudative maculopathy associated with deterioration of vision. Focal argon laser photocoagulation was carried out to areas having the highest concentration of incom petent capillaries. Visual acuity in one patient improved from 6/36 to 6/18 within three months of therapy with gradual absorption of macular fluid (Fig. 4) . Vision has been main tained at this level for eight months. The second patient has only had recent therapy and is still under follow-up. One patient in the series with proliferative retinopathy and pre retinal haemorrhage was advised to have ther apy; however, treatment was declined.
Discussion
Radiation retinopathy is a well documented complication of ocular and orbital radiation and although the various elements of the ret ina show a spectrum of sensitivity to radiation the cells of the retinal microvasculature are among the most radiosensitive. Radiation injury to the retinal vascular cells leads to vessel closure4•8.1 6 and an ischaemic retino pathy which has more disastrous con- There is oedema and exudation superior to the right macula (visual acuity 6/36).
sequences on the retinal neuropile than the direct effects of radiation. Although the total dose of radiation to the retina is probably the most important factor in determining whether retinopathy develops other therapeutic para meters are also important, particularly the size of the fractionation dose,5, 6 ,IO,11 the timing of treatment and the energy of the radiation source.3, 7 Other factors which may influence the development of retinopathy are the con current use of chemotherapyl2 , 19 and systemic conditions such as diabetes, hypertension and collagen diseases. 1 0 , 1 6 , 2 0 The exact amount of radiation required to precipitate retinopathy is not known although several studies of orbital radiation for oph thalmic Graves' disease indicate that 2000 cGy of radiotherapy can be tolerated without the development of retinopathy. [21] [22] [23] Bessel et al.17 found no retinopathy in 73 patients receiving 3000-4000 cGy for orbital lymphomata although Mewis et at. 24 did find retinopathy in three patients given 2500-3000 cGy for choroidal metastasis. These data are in accord with the present study which demonstrates retinopathy in all patients receiving over 3400 cGy to the orbit. It there fore seems likely that the threshold dose for radiation damage to the retinal vasculature lies between 2500 and 3000 cGy when X-ray or gamma sources are employed.
In the present study the incidence of radi ation retinopathy was highest in those patients receiving radiation directly to the eye and orbit and those sites in close proximity to the orbit where shielding is not possible, ie the paranasal sinuses and the nasopharynx. The incidence of retinopathy following irradiation of the paranasal sinuses is lower than that reported by Medina et al., however, these workers used significantly higher doses of radiation and the eye and orbit were included in the field of irradiation. The occurrence of retinopathy following irradiation of the naso pharynx was typically lower than for the para nasal sinuses and the figure of 36.4% is identical to that reported by Medina et al. It is obvious that the relationship of radiation ret inopathy to the site of cephalic radiotherapy is based on the proximity of the target site to the eye and hence the amount of radiation received by the retina.
There are considerable difficulties in deter mining the exact amount of radiation received by the retina in patients having treatment for tumours of the paranasal sinuses, naso pharynx and cerebrum. Antral irradiation delivers a significant dose to the retina and optic nerve because the roof of the antrum rises postero-medially (to about the level of the cornea).4,25 Furthermore, the orbit may be involved by extension of the tumour thus necessitating inclusion of the orbit in the field of treatment.4,9 Similar considerations would apply to treatment of the ethmoid sinuses and nasopharynx since direct extension may occur to involve the orbit and/or the sphenoid bone.8,9
While treatment of malignant disease should not be compromised to avoid ocular complications the extent of disease should be evaluated by CT scan and in the absence of orbital extension the dose of radiation to the orbit could be significantly controlled through individualised planning of the treatment fields and the uSe of highly collimated beams.
There have been anecdotal reports that pre-existing diabetes lowers the threshold at which radiation retinopathy occurs. 1 6 ,2 0 This is not surprising since both diseases are occlu sive microangiopathies. Becuase of this syn ergism it is particularly important that radiation doses in diabetics should be closely monitored and possibly reduced.
Radiation retinopathy has a variable and often delayed onsee,4,8,1 0 which in the present study was found to be as long as eight years. It is thus important to institute adequate fol low-up for patients receiving cephalic radiation.
Radiation vasculopathy has been known to take a variable course. Although vascular remodelling was reported by Bagan et al. 13 and Noble et al.2 6 there is a general tendency for the vasculopathy to progress.8,9,1 6 The macular microvasculature seems to be the most vulnerable, and typically shows sac-like dilatations, micro aneurysms and capillary fallout.4,8,1 6 ,2 7 ,28 As in other conditions these alterations lead to vascular incompetence and leakage.
Many small series have shown successful treatment of advancing radiation vasculo pathy by laser photocoagulation, based on the same treatment principles as in diabetic retinopathy.29,30 Focal laser photocoagulation is applied to areas of microvascular incom petence, especially in the macular area. 2 7 -29 Significant macular ischaemia is a contra indication to photocoagulation, as it is in dia betic maculopathy. Neovascularisation of the retina or optic disc is treated by laser photo coagulation (either sector or panretinal) to obliterate the ischaemic retina. 8 , 29 -31 As in diabetes vitrectomy is indicated where there is persistent vitreous haemorrhage or traction retinal detachment which threatens the macular.29
Conclnsions
Retinal vasculopathy after cephalic radiation is more common than previously thought. Patients receiving radiotherapy for orbital tumours have a higher risk of developing radi ation retinopathy if the total dose exceeds 300 ? cGy. Up to 41 % of patients receiving radiotherapy to the nasopharynx, paranasal sinuses and the nasal cavities are also likely to develop radiation retinopathy. However, radiation of brain tumours carries a relatively small risk.
.
Radiation retinopathy develops slowly often taking up to eight years or longer to become observable or visually significant. Most microvascular lesions progress slowly and in a significant proportion of patients (about 50%) sight threatening complications develop. Laser photocoagulation is useful in limiting the degree of macular oedema and containing vasoproliferation. With appro priate management most patients will main tain adequate vision for prolonged periods.
Patients with diabetes and diabetic retino pathy are particularly sensitive to the super imposed insult of ionising radiation and should be closely supervised following treatment.
Better co-operation between the radio therapist and the ophthalmologist in treat ment planning and the development of an after care plan for the patient receiving cephalic radiation will help reduce ocular morbidity.
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